QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
Log in
NYSE:HUGE

FSD Pharma Stock Forecast, Price & News

$1.96
-0.17 (-7.98 %)
(As of 02/26/2021 02:26 PM ET)
Add
Compare
Today's Range
$1.95
Now: $1.96
$2.16
50-Day Range
$1.92
MA: $2.30
$3.87
52-Week Range
$1.28
Now: $1.96
$14.00
Volume52,279 shs
Average Volume3.56 million shs
Market Capitalization$37.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone(416) 854-8884
Employees17
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$37.56 million
Next Earnings DateN/A
OptionableOptionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Medical Sector

993rd out of 1,956 stocks

Drug Manufacturers—Specialty & Generic Industry

14th out of 63 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.96
-0.17 (-7.98 %)
(As of 02/26/2021 02:26 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HUGE News and Ratings via Email

Sign-up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











FSD Pharma (NYSE:HUGE) Frequently Asked Questions

Is FSD Pharma a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FSD Pharma in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" FSD Pharma stock.
View analyst ratings for FSD Pharma
or view top-rated stocks.

What stocks does MarketBeat like better than FSD Pharma?

Wall Street analysts have given FSD Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but FSD Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are FSD Pharma's key executives?

FSD Pharma's management team includes the following people:
  • Dr. Raza Bokhari M.B.A., M.D., MBA, Exec. Chairman & CEO (Age 53)
  • Mr. Anthony John Durkacz, Founder & Director (Age 45)
  • Mr. Donal Carroll CPA, Chief Financial Officer (Age 44)
  • Ms. Maryann Adesso, Chief of Staff
  • Dr. Sara May Ph.D., Sr. VP
  • Dr. Sandra R. Lottes, VP & Head of Clinical Research of FSD BioSciences, Inc
  • Dr. Edward J. Brennan Jr., F.A.C.S., M.D., FACS, Pres of FSD BioSciences, Inc

Who are some of FSD Pharma's key competitors?

What other stocks do shareholders of FSD Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include JD.com (JD), Docebo (DCBO), salesforce.com (CRM), Canadian Natural Resources (CNQ), Chipotle Mexican Grill (CMG), Cloudera (CLDR), Caterpillar (CAT), Black Stone Minerals (BSM), Best Buy (BBY) and Alibaba Group (BABA).

What is FSD Pharma's stock symbol?

FSD Pharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUGE."

Who are FSD Pharma's major shareholders?

FSD Pharma's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.24%) and Rossmore Private Capital (0.12%).

Which major investors are buying FSD Pharma stock?

HUGE stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and Rossmore Private Capital.

How do I buy shares of FSD Pharma?

Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is FSD Pharma's stock price today?

One share of HUGE stock can currently be purchased for approximately $1.96.

How much money does FSD Pharma make?

FSD Pharma has a market capitalization of $37.56 million.

How many employees does FSD Pharma have?

FSD Pharma employs 17 workers across the globe.

What is FSD Pharma's official website?

The official website for FSD Pharma is fsdpharma.com.

How can I contact FSD Pharma?

The company can be reached via phone at (416) 854-8884.


This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.